Cargando…

High positive rate after consecutive negative tests of SARS-CoV-2

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a global public health event since 2019. Real-time reverse transcription polymerase chain reaction (RT-PCR) assays of upper respiratory tract specimens were used as the most common method for confirmation of SARS-CoV-2. Patients d...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Tingting, Wang, Zhongliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063252/
https://www.ncbi.nlm.nih.gov/pubmed/37000085
http://dx.doi.org/10.1097/MD.0000000000033333
_version_ 1785017671255851008
author Du, Tingting
Wang, Zhongliang
author_facet Du, Tingting
Wang, Zhongliang
author_sort Du, Tingting
collection PubMed
description Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a global public health event since 2019. Real-time reverse transcription polymerase chain reaction (RT-PCR) assays of upper respiratory tract specimens were used as the most common method for confirmation of SARS-CoV-2. Patients diagnosed with coronavirus disease 2019 and hospitalized in Cancer Center of Wuhan Union Hospital were retrospectively enrolled. Epidemiological, clinical, and laboratory records were analyzed with highlights on the pattern of results of repeated RT-PCR tests. Nine hundred eighty-four patients admitted to hospital between February 13, 2020 to March 10, 2020 were enrolled. The median age was 62.0 years (interquartile range 49.0–68.0) and 44.5% was male. Three thousand-three hundred eleven specimens were collected for RT-PCR tests with a median of 3 tests (interquartile range 2.0–4.0) per patient. Three hundred sixty-two (36.8%) patients showed positive records from repeated RT-PCR tests. For the 362 confirmed patients, 147 cases received further RT-PCR tests after 2 consecutive negative records of SARS-CoV-2 and 38 (26%) of them obtained a positive result. Ten (23%) of 43 patients showed positive results after 3 consecutive negative tests and 4 (24%) of 17 patients were positive after 4 negative tests. Consecutive negative RT-PCR tests with respiratory specimens could not guarantee a viral clearance.
format Online
Article
Text
id pubmed-10063252
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-100632522023-03-31 High positive rate after consecutive negative tests of SARS-CoV-2 Du, Tingting Wang, Zhongliang Medicine (Baltimore) 4400 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a global public health event since 2019. Real-time reverse transcription polymerase chain reaction (RT-PCR) assays of upper respiratory tract specimens were used as the most common method for confirmation of SARS-CoV-2. Patients diagnosed with coronavirus disease 2019 and hospitalized in Cancer Center of Wuhan Union Hospital were retrospectively enrolled. Epidemiological, clinical, and laboratory records were analyzed with highlights on the pattern of results of repeated RT-PCR tests. Nine hundred eighty-four patients admitted to hospital between February 13, 2020 to March 10, 2020 were enrolled. The median age was 62.0 years (interquartile range 49.0–68.0) and 44.5% was male. Three thousand-three hundred eleven specimens were collected for RT-PCR tests with a median of 3 tests (interquartile range 2.0–4.0) per patient. Three hundred sixty-two (36.8%) patients showed positive records from repeated RT-PCR tests. For the 362 confirmed patients, 147 cases received further RT-PCR tests after 2 consecutive negative records of SARS-CoV-2 and 38 (26%) of them obtained a positive result. Ten (23%) of 43 patients showed positive results after 3 consecutive negative tests and 4 (24%) of 17 patients were positive after 4 negative tests. Consecutive negative RT-PCR tests with respiratory specimens could not guarantee a viral clearance. Lippincott Williams & Wilkins 2023-03-31 /pmc/articles/PMC10063252/ /pubmed/37000085 http://dx.doi.org/10.1097/MD.0000000000033333 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC) (https://creativecommons.org/licenses/by-nc/4.0/) , where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal.
spellingShingle 4400
Du, Tingting
Wang, Zhongliang
High positive rate after consecutive negative tests of SARS-CoV-2
title High positive rate after consecutive negative tests of SARS-CoV-2
title_full High positive rate after consecutive negative tests of SARS-CoV-2
title_fullStr High positive rate after consecutive negative tests of SARS-CoV-2
title_full_unstemmed High positive rate after consecutive negative tests of SARS-CoV-2
title_short High positive rate after consecutive negative tests of SARS-CoV-2
title_sort high positive rate after consecutive negative tests of sars-cov-2
topic 4400
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063252/
https://www.ncbi.nlm.nih.gov/pubmed/37000085
http://dx.doi.org/10.1097/MD.0000000000033333
work_keys_str_mv AT dutingting highpositiverateafterconsecutivenegativetestsofsarscov2
AT wangzhongliang highpositiverateafterconsecutivenegativetestsofsarscov2